SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-041847
Filing Date
2017-02-14
Accepted
2017-02-14 07:01:03
Documents
1
Group Members
SHARON SHACHAM

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 3 d326157dsc13ga.htm SC 13G/A 58827
  Complete submission text file 0001193125-17-041847.txt   60158
Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE, SECOND FLOOR NEWTON MA 02459
Business Address
Kauffman Michael (Filed by) CIK: 0001364719 (see all company filings)

Type: SC 13G/A

Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Subject) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87705 | Film No.: 17602322
SIC: 2834 Pharmaceutical Preparations